from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3432c/gadB

LFCtreatmentdescriptionclass of inhibitor

-1.540

Amikacinug/mL Amikacintranslation

-0.692

Cap5-10ug/mL Capreomycintranslation

0.380

Rox10-50 ug/mL Roxithromycintranslation

-1.347

SM2-5 ug/mL Streptomycintranslation

-2.433

Tet5-10 ug/mL Tetracyclinetranslation

-0.229

Rif0.2-5ug/mL Rifampicintranscription

-0.665

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.355

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.073

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.452

CPZ10-50 ug/mL Chlorpromazinerespiration

0.673

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.089

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.724

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.055

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.028

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.353

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.839

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.657

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.368

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.331

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.466

KCN5-20 ug/mL Potassium cyaniderespiration

0.346

NaN30.2-2 mM Sodium aziderespiration

1.174

Nigericin50 uM Nigericinrespiration

-0.737

TRC10-150 ug/mL Triclosanrespiration

1.363

TRZ10-25 ug/mL Thioridazinerespiration

-0.354

Valinomycin0.5-10 uM Valinomycinrespiration

0.156

ZnSO42 mM ZnSO4respiration

0.670

menadione6-10 ug/mL Menadionerespiration

-0.666

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.022

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.332

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.247

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.330

NRP_1Non-replicating persistence stage 1dosRassociated

-0.210

Amp0.2mg/mL AmpicillincellWall

0.264

Cephalexin20-100 ug/mL CephalexincellWall

-0.344

Cerulenin0.32-5 ug/mL CerulenincellWall

0.114

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.465

EMB10-20 ug/mL EthambutolcellWall

-0.913

Eta12-40 ug/mL EthionamidecellWall

-1.236

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.486

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.200

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.632

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.892

BZA0.12 mg/mL BenzamidearomaticAmides

0.079

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.145

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.071

H2O24 mM hydrogen peroxideDNAdamaging

-0.495

Levo10 ug/mL LevofloxacinDNAdamaging

-0.642

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.129

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.986

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.154

UVUV-irradiationDNAdamaging

1.276

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.925

Antimycin12.5-50 ug/mL Antimycin A?

0.712

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.701

PA_110-50 ug/mL Antitubercular compound PA-1?

0.051

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.713

PA8240.2-2 ug/mL PA-824?

-0.225

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.503

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

1.385

Verapamil50 uM Verapamil?

0.999

mercaptoethanol2 mM 2-Mercaptoethanol?

0.842

methoxatin10-20 ug/mL Methoxatin?